An Amibitious Couple's Blog Experiment

Seattle Genetics President, Clay Siegall

 

Clay Siegall, Ph.D., is the chief executive officer of Seattle Genetics. Clay’s WordPress page is filled with a broad range of topics, mostly scientific discoveries and issues like global warming. He recently posted about an article on NPR. It was about how seafood guides are so confusing, yet people want to eat healthy. Most sellers at food outlets seem to have little knowledge about the seafood they acquire.

Scientists claim that finding the right kind of seafood depends on some factors: where the fish comes from, how it was captured/farmed and the effect it had on the local environment. Seafood guides vary so the best way to gauge their sustainability is to check if they are based on scientific research. He also posted about President Donald Trump’s decision to stop climate change funding. Trump had long termed climate change a hoax, and it was no surprise when he made the decision. While some people were critical about this, Trump’s government considered climate change a waste of money.

Dr. Siegall co-founded Seattle Genetics in 1998 and currently acts as the company’s president, chief executive officer and chairman of the board. He is a trained scientist specializing in targeted cancer therapies. Under the leadership of Clay, Seattle Genetics has achieved success by concentrating on helping patients, engaging in extensive research and development of drugs. These efforts have enabled Seattle Genetics to become a leader in developing antibody-drug conjugates (ADCs). Clay has always had the desire to help cancer patients since he started his career in the biomedical sector.

In his proffesion, Dr. Clay Siegall has achieved a lot. Before he co-founded Seattle Genetics, he worked with Bristol-Myers Squibb Pharmaceutical Research Institute (1991-1997) as a senior research investigator. He was later promoted to the post of principal scientist. He then joined the National Cancer Institute where he was a Staff Fellow and Biotechnology Fellow. Dr. Siegall helped fundraise more than $1.2 billion in private and public funding for his company. The capital has played a huge role in enabling Seattle Genetics to use the most advanced technology in research and treatment of cancer. He currently holds fifteen patents and is still as dedicated as ever in his efforts to alleviate the suffering of cancer patients.

 

Leave a comment for: "Seattle Genetics President, Clay Siegall"

Tag Cloud